baber/WOPTO huggingface dataset:
Patent DE-60311385-T2 (DE)
Inventor: TAST NIILA
IPC: E02D5/80
Filed: 2003-11-04
Granted: 2007-05-31
Abstract: The anchoring arrangement comprises at least two anchoring plates (2) that are arranged on different sides of the object to be anchored. The anchoring plates are connected to each other by a connecting means (3) that extends over the object to be anchored. The anchoring plates are placed in the same pit as the object to be anchored and a layer of earth is arranged on top of them. The anchoring plates are mounted so deep that the weight of the layer of earth on top of the anchoring plates prevents the object to be anchored from rising due to water's buoyancy.
Patent DE-60314648-T2 (DE)
Inventor: SCARSBROOK GEOFFREY ALAN
IPC: C30B29/04
Filed: 2003-09-19
Granted: 2007-10-25
Abstract: A method of producing a large area plate of single crystal diamond from CVD diamond grown on a substrate substantially free of surface defects by chemical vapour deposition (CVD). The homoepitaxial CVD grown diamond and the substrate are severed transverse to the surface of the substrate on which diamond growth took place to produce the large area plate of single crystal CVD diamond.
Patent DE-60315732-T2 (DE)
Inventor: D ORIA FRANCESCO
IPC: B29C48/92
Filed: 2003-06-30
Granted: 2008-06-05
Abstract: A process for manufacturing elastomeric components of a tire for a vehicle wheel includes feeding a continuous elongated element from a delivery member by exerting a feeding pressure inside the delivery member, rotating a building support around a geometrical rotation axis of the support, carrying out controlled relative displacements between the delivery member and the support to form a tire component, stopping the feeding of the elongated element when formation of the tire component is complete, and exerting a counter-pressure inside the delivery member after stopping the feeding. Rotating the support assists circumferential distribution of the elongated element on the support. Carrying out controlled relative displacements assists transverse distribution of the elongated element on the support. The tire component is defined by a plurality of coils laid in a pre-established deposition pattern depending on a predetermined cross-section outline to be given to the tire component.
Patent DE-60317134-T2 (DE)
Inventor: SCHARY PHILIPPE
IPC: G02C3/00
Filed: 2003-03-26
Granted: 2008-08-07
Abstract: The face mask, comprising a screen (12) inside a surround (2) e.g. of a plastic material with two side pieces (5, 6) connecting it to a head strap (14), has the head strap connected to the surround by a supple cord (23, 24) of a synthetic material on each side. The cords are attached to the surround at two points (16, 17; 18, 19) spaced 30 - 40 mm apart along the side pieces, and each one passes round a curved slider (36) attached to the ends of the head strap.
Patent DE-60317581-T2 (DE)
Inventor: MEERDINK JOHANNES
IPC: C07C55/28
Filed: 2003-12-10
Granted: 2008-09-04
Abstract: The present case relates to a process for the purification of lactide from a crude lactide vapor product stream which process comprises a rectification/condensation step leading to a lactide-enriched condensate.
Patent DE-68902350-T2 (DE)
Inventor: BRUININK PETER
IPC: B32B15/08
Filed: 1989-05-03
Granted: 1993-03-18
Abstract: Ballistic structure comprising a solid combination of a metal first layer and an second layer consisting of a composite fibre material containing fibres with a tensile strength of at least 2 GPa and a modulus of at least 20 GPa, based on polyethyelene with a weight average molecular weight of at least 4 * 10<5> and a thermoplastic binding agent shows good ballistic properties if a binding layer is applied between the first layer and the second layer, which binding layer contains a modified polyolefin.
Patent DE-68908491-T2 (DE)
Inventor: JONASSEN IB
IPC: C12N15/17
Filed: 1989-06-20
Granted: 1994-01-20
Abstract: The invention relates to insulin precursors having the amino acid sequence  B(1-29)-X1-X2-Y2-Y1-A(1-21) wherein B(1-29) are the 29 first amino acid residues of the B chain of human insulin, A(1-21) are the 21 amino acid residues of the A chain of human insulin, X1 represents a peptide bond or one or more amino acid residues, X2 represents Glu or Asp, and Y1 and Y2 each represent Lys or Arg, the positions A6 and A11, A7 and B7 and A20 and B19, respectively, being connected through sulphur bridges, and, optionally, one or more of the amino acid residues of chains B(1-29) and A(1-21) are substituted by another amino acid residue. The insulin precursors are prepared by culturing a yeast strain transformed with a replicable expression vehicle comprising a DNA sequence encoding the insulin precursor and isolating it from the culture medium. The insulin precursors can be converted into human insulin or insulin analogues by enzymatic treatment.
Patent DE-68922053-T2 (DE)
Inventor: KATO MASAYUKI
IPC: A61P25/04
Filed: 1989-09-21
Granted: 1995-08-10
Abstract: A compound of the formula : <CHEM>  wherein  R<1> is hydrogen, lower alkyl or lower alkenyl  R<2> is hydrogen, lower alkyl or halogen, R<3> is imidazolyl or pyridyl, each of which may have suitable substituent(s), and R<4> is hydrogen, lower alkyl, lower alkenyl or hydroxy(lower)alkyl and R<5> is hydrogen, hydroxy or acyloxy, or  R<4> and R<5> are linked together to form an additional bond, and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them in association with the pharmaceutically acceptable, substantially non-toxic carrier or excipient.
Patent DE-68923459-T2 (DE)
Inventor: BLANC CLAUDE
IPC: C10G5/04
Filed: 1989-11-14
Granted: 1996-04-04
Abstract: The gas mixture to be treated (1) is washed (5) between 0 DEG C and -45 DEG C by means of a solvent (6) for CO2 and C3 and higher hydrocarbons to produce a methane stream (8) containing not more than 2 mol% of CO2 and a CO2-rich liquid phase (11) containing at least 80 mol% of C3 and higher hydrocarbons from the gas mixture (1). The liquid phase (11) is subjected to a demethanization (12, 17) producing a demethanized rich solvent (27) and a methane-rich gas phase (22), and then the rich solvent (27) is subjected to a regeneration producing a regenerated solvent (34) which is recycled into the washing zone (5), and a gas mixture (42) containing the CO2 and the C2 and higher hydrocarbons which are present in the methanized rich solvent, the said gas mixture being separated by regenerative washing with a C5 and higher hydrocarbon solvent, into a CO2-rich acidic gas stream containing, expressed as methane equivalent, less than 10 mol% of hydrocarbons, and into a C2 and higher hydrocarbon cut (48) containing at least 80 mol% of the C3 and higher hydrocarbons present in the gas to be treated (1).
Patent DE-68927885-T2 (DE)
Inventor: BANNAI KIYOSHI
IPC: A61K31/557
Filed: 1989-12-21
Granted: 1997-06-26
Abstract: Pharmaceutical compsns. for the treatment and prophylaxis of intestinal disorders contain a (hetero)isocarbacyclin of formula (I) as active component: (where R1 is H, 1-10C alkyl, -CH2COOR" or a monovalent cation; R" is H or 1-10C alkyl; R2 is H or methyl; R3 is 3-10C alkyl, 3-10C alkenyl, 3-10C alkynyl, 3-10CG cycloalkyl, (3-10C cycloalkyl)-1-6C alkyl), or phenyl or phenoxy opt. substd. by halogen, OH, 27 2-7C acyloxy, 1-6C alkyl, 1-6C haloalkyl, 1-4C alkoxy, 1-4C haloalkoxy, CN, carboxy or 1-6C alkoxycarbonyl; n is 0 or 1; Q is a gp. of formula -(CH2)4COOR' (II), -CH2-X-CH2CH2COOR' (III), -CH2CH2-Y-CH2COOR' (IV); X and Y are O or S).
Patent DE-68928415-T2 (DE)
Inventor: STANLEY THEODORE
IPC: A61K38/095
Filed: 1989-09-05
Granted: 1998-02-26
Abstract: The present invention is directed to methods and compositions for noninvasively administering lipophilic drugs in a dose-to-effect manner to produce antimigraine, oxytoxic, antiemetic, hypoglycemic, anti-Parkinsonian, antidiuretic, antifungal, antisecretory, or bronchodilator activity. A patient is put at ease when given the lollipop, and the lipophilic drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and terminate the use of the lollipop when it has had a desired effect on the patient. The drug-containing lollipop can be self-administered by the patient in response to subjective symptoms and to the patient's susceptibility to the lipophilic drug.
Patent DE-69008985-T2 (DE)
Inventor: MERRILL DERRICK
IPC: B23B51/04
Filed: 1990-09-26
Granted: 1994-09-01
Abstract: A tipped annular hole cutter is made by brazing all the cutting tips (30) simultaneously to the cylindrical wall (12) of the cutter body. The tips (30) have outer and inner lands (32, 34) which locate against the outer and inner surfaces (52, 54) of the cylindrical wall (12). This accurately locates the tips radially during brazing. The radially inner face (46) of the tip (30) is inclined so as to define an inner clearance face which has the necessary circumferential and radial clearances without there being any need to grind the inner face (46) after brazing. The tips (30) are received in skewed slots (18) whose angle of skew (alpha) is less than the angle of spiral (beta) of the flutes (70). The front rake face (43) is ground to provide an optimum cutting action whereas the flutes are designed independently to achieve optimum chip removal.
Patent DE-69016069-T2 (DE)
Inventor: ALBOUY PIERRE
IPC: H04B10/50
Filed: 1990-03-19
Granted: 1995-05-18
Abstract: The device permits selection of one data source from two sources, and regulation of the laser current. It comprises a current generator (A) controlled by an activation signal (ACT) and delivering a laser current (I) which can be regulated by an external means, a selection circuit (B) connected to two data sources, and an output modulator (7) connected at input to the current generator (A) which supplies it with the laser current (I) and to the selection circuit (B) which supplies it with the data to be transmitted, and at output to the laser which it supplies with the laser current (I) modulated by the said data to be transmitted. In the absence of data to be transmitted, the activation signal has a value such that it blocks the current generator (A) so that the laser is not fed. 
<IMAGE>
Patent DE-69023124-T2 (DE)
Inventor: SIRCOM RICHARD
IPC: A61M5/32
Filed: 1990-02-01
Granted: 1996-11-14
Abstract: A needle tip protecting device is provided for catheters having an insertion needle. The device is small enough to be stored at the base of the catheter needle prior to and during use. After use it may be slip to cover the needle tip where it automatically self-attaches and becomes non-removable. Various embodiments of mechanisms to achieve this effect are described.
Patent DE-69024222-T2 (DE)
Inventor: ILOMAEKI VALTO
IPC: E21B44/00
Filed: 1990-09-27
Granted: 1996-08-22
Abstract: PCT No. PCT/FI90/00232 Sec. 371 Date Mar. 17, 1992 Sec. 102(e) Date Mar. 17, 1992 PCT Filed Sep. 27, 1990 PCT Pub. No. WO91/05138 PCT Pub. Date Apr. 18, 1991.A method for controlling advancement of a drilling apparatus comprising a drill head having tools therein and at least one conveying tube is disclosed. The method utilizes changes in pressure sensed in the drill head or the conveying tube as a means for assessing forces acting on tools in the drill head. The measured pressure information is transmitted to control equipment which adjusts the driving force applied by a power unit to the apparatus to effect the drilling operation. The method thereby provides an effective means of preventing damage to the tools.
Patent DE-69027666-T2 (DE)
Inventor: MILLER JAMES
IPC: A61K38/27
Filed: 1990-08-21
Granted: 1996-11-07
Abstract: A novel method for refolding reduced IGF-I is provided in accordance with the present invention. The method is carried out by providing additional positive charge at the amino terminal end of the IGF-I molecule by the presence of a short leader sequence. The additional positive charge on the met-end of the IGF-I molecule has been found to enable recombinant IGF-I to refold simply by stirring solubilized inclusion body protein for between 2-16 hours, or overnight. The present invention also provides a novel fusion protein intermediate of IGF-I attached to the positively charged leader sequence.
Patent DE-69100410-T2 (DE)
Inventor: LILLA STEFANIA
IPC: A47K10/06
Filed: 1991-02-13
Granted: 1994-02-03
Abstract: The bracket is supported by a supporting structure (2) having one row of parallel columns (3) at a predetermined distance from one another and having an object carrier member (5) and at least one connector (4) for fixing to the structure (2) and for support of the said member (5). The connector (4) has a portion forcibly inserted between two contiguous columns (3) and includes two bodies (6) each of which has a first face in which there is formed a seat (12) engaged by the corresponding column (3) and a second face in contact with a second face of the other body (6).
Patent DE-69102654-T2 (DE)
Inventor: MUCKENFUHS DELMAR
IPC: B65D85/07
Filed: 1991-10-24
Granted: 1994-10-27
Abstract: A flexible package preferably comprised of paper and having an opening system that controls and reduces the initial removal forces required to withdraw the compressed flexible articles from the package after the opening device portion of the system has been activated. A reinforcement sheet located at the lowermost end of the opening system protects the flexible articles contained within the package prior to activation of the opening device, and provides additional support for the package prior to opening. A substantially vertically oriented line of weakness located in the reinforcement sheet ruptures automatically when the opening device is activated permitting the flexible articles to fan out further from the package. This automatic rupturing of the reinforcement sheet reduces the compressive forces acting upon the compressed flexible articles. This in turn permits easier removal of the first few flexible articles from the package either one at a time or in multiples.
Patent DE-69102676-T2 (DE)
Inventor: BAUM JOHN MICHAEL
IPC: A61L2/18
Filed: 1991-04-09
Granted: 1994-10-27
Abstract: The use of lantibiotics as bactericidal agents against Gram negative food-borne pathogens or Gram negative spoilage organisms such as Salmonella. Previously, nisin was believed to be effective only against Gram positive bacteria. It has now been found that with the removal of impurities from commercially available nisin preparations in particular sodium chloride, nisin in an environment having a pH of between about 5.5 and about 6.5 is an effective bactericidal agent against Gram negative bacteria.
Patent DE-69120713-T2 (DE)
Inventor: MACHADO JOSEPH MICHAEL
IPC: C08L33/04
Filed: 1991-04-09
Granted: 1997-02-13
Abstract: Improved compositions comprise polymer blends of (1) a linear alternating polymer of carbon monoxide and at least one ethylenically unsaturated hydrocarbon with (2) a high rubber graft copolymer, and, optionally, (3) an acidic polymer containing moieties of an  alpha -olefin and an  alpha , beta -ethylenically unsaturated carboxylic acid. The blends demonstrate improved toughness and impact strength at both ambient and low temperatures.
Patent DE-69123661-T2 (DE)
Inventor: BERGER PAUL D
IPC: C09K23/00
Filed: 1991-08-01
Granted: 1997-05-28
Abstract: New surfactant compositions comprising a polyoxyalkylene alkylamine containing at least 7 moles of an oxyalkylene group and having reduced eye irritancy. The surfactant compositions can contain eye irritant reducing compounds such as sulfated polyoxyalkylene alkylphenol, alcohol sulfates; polyoxyalkylene alcohol sulfates; mono- and dialcohol phosphates; mono- and di-(polyoxyalkylene alcohol) phosphates; polyoxyalkylene alkylphenol carboxylates and polyoxyalkylene alcohol carboxylates, said eye irritant reducing compounds containing up to about 60 moles of an alkylene oxide group and its alkyl and alcohol groups having from about 8 to about 20 carbon atoms. The new surfactant compositions can be used to prepare pesticidal compositions.
Patent DE-69126568-T2 (DE)
Inventor: MATSUO HISAYUKI
IPC: A61K38/00
Filed: 1991-07-12
Granted: 1997-11-27
Abstract: A peptide composed of 53 amino acid residues represented by the following amino acid sequence: <IMAGE> and derivatives thereof represented by the following amino acid sequence: <IMAGE> wherein X is as shown in the specification, are disclosed. These polypeptides are novel and have natriuretic and hypotensive actions.
Patent DE-69127447-T2 (DE)
Inventor: CONSTANTZ BRENT
IPC: C01B25/32
Filed: 1991-07-05
Granted: 1998-01-29
Abstract: Novel compositions are provided for the production of hydroxyapatite, where a dry mixture is provided which combines a calcium source and an acidic phosphate source, particularly monocalcium phosphate monohydrate or orthophosphoric acid crystals. These two are combined, optionally with other ingredients, with mechanical mixing, resulting in partial reaction or intimate combination to produce a product which requires less water for formation of a desired viscosity, has enhanced mechanical properties and is physiologically acceptable.
Patent DE-69130423-T2 (DE)
Inventor: LEE HENRY J
IPC: D21F1/10
Filed: 1991-03-15
Granted: 1999-04-22
Abstract: A papermakers fabric having a system of flat monofilament machine direction yarns 22,23 (hereinafter MD yarns) interwoven with a system of cross machine direction yarns 21a,21b (hereinafter CMD yarns). The MD yarns 22,23 have an aspect ratio of greater than 3:1. Furthermore the MD yarns are vertically stacked with at least paired upper 22 and lower 23 MD yarns which weave over and under CMD yarns 21a,21b in such a manner that when a lower MD yarn 23 weaves over a CMD yarn 21a an upper MD yarn 22 is weaving (or floating) over the lower MD yarn 23. This ensures that no knuckles are apparent on the upper surface of the fabric. The weave gives rise to a warp-fill in the range of 80-125%.
Patent DE-69131908-T2 (DE)
Inventor: YEE JIING-KUAN
IPC: C12N15/87
Filed: 1991-08-09
Granted: 2000-08-17
Abstract: The present application discloses the incorporation of specific membrane-associated proteins into enveloped vector particles to provide an altered host range for these viruses. As a model system, the incorporation of the VSV G protein into Moloney murine leukemia virus (MoMLV)-based retroviral vectors is disclosed. The application discloses methods of introducing genes using modified viruses, and the modified viruse's associated nucleic acid, proteins and cell lines. The methods of introducing genes are disclosed to be useful in a variety of gene therapy methods.
Patent DE-69207446-T2 (DE)
Inventor: MEYHOFF HENRY
IPC: B65D5/46
Filed: 1992-02-12
Granted: 1996-06-27
Abstract: A pack or pack blank erected by folding from opposed sides of a four sided sleeve a first pair of end portions of less width than the finished overall width of the pack, then folding from the other two sides of the sleeve a second pair of end portions, double scored to form inner and distal sections, the distal sections of the second pair being located by the edges of the already folded first pair so that the double scoring gives rise to chamfered corners. <IMAGE>
Patent DE-69215190-T2 (DE)
Inventor: STOMP HUBERT
IPC: C21C5/46
Filed: 1992-09-28
Granted: 1997-05-15
Abstract: Device for automatic coupling between conduits on a metallurgical treatment station (2) and conduits on a metallurgical ladle (1). The half-coupling (4) associated with the treatment station is supported by a movable element and is kept in a protected stand-by position on the station (2) in order to be automatically positioned by first means in a coupling position with the half-coupling (5) associated with the ladle (1) just before deposition of the ladle (1) on its seat (3) provided on the station (2). Second means bring the movable element supporting the half-coupling (4) back into the protected stand-by position at the moment when the ladle (1) is withdrawn from its seat. <IMAGE>
Patent DE-69219740-T2 (DE)
Inventor: BOIE WERNER
IPC: H04N9/64
Filed: 1992-12-04
Granted: 1997-09-11
Abstract: In TV systems like SECAM, MAC, MUSE, etc. the chrominance signals are transmitted on alternate lines. Precautions have to be taken in account in order to avoid sampling artefacts, but these precautions are not made in each of these standards. According to the invention the chrominance signal can be prefiltered prior to alternate line omission and post-filtered for a full-line display. The inventive adaptive filter for improving the picture quality uses additional information from the other colour component or even from the luminance signal. <IMAGE>
Patent DE-69220046-T2 (DE)
Inventor: GRIFFITHS JOHN THE ARK WESTVIE
IPC: F02C3/28
Filed: 1992-03-06
Granted: 1998-01-22
Abstract: PCT No. PCT/GB92/00407 Sec. 371 Date Sep. 13, 1993 Sec. 102(e) Date Sep. 13, 1993 PCT Filed Mar. 6, 1992 PCT Pub. No. WO92/15775 PCT Pub. Date Sep. 17, 1992An integrated gasification combined cycle (IGCC) process and plant are provided in which an improvement in overall thermodynamic efficiency can be achieved by increasing the proportion of power generated by gas turbine(s) to that generated by steam turbine(s). This is achieved by placing an exothermic catalytic reactor downstream of the gasifier to pre-heat the gas turbine fuel gas which is supplemented by the addition of non-combustible gas.
Patent DE-69224623-T2 (DE)
Inventor: LAEHDEMAEKI HEIMO
IPC: H04M3/00
Filed: 1992-10-28
Granted: 1998-08-20
Abstract: Converging of an echo canceller (4A-D) integrated into a telephone exchange (1, 2) is initiated at the start of a telephone call by an internal command of the telephone exchange given by a call control (2) of the telephone exchange as soon as the call control (2) has observed an off-hook state of a called subscriber connection. The command causes the echo canceller (4A-D) to transmit a test signal to the echo path for converging the echo canceller before appearance of the speech signal.
Patent DE-69228457-T2 (DE)
Inventor: MAKINO TADASHI
IPC: A61J3/10
Filed: 1992-09-09
Granted: 1999-06-17
Abstract: A tablet having first and second surfaces opposite to each other and a side surface lying perpendicular to any one of the first and second surfaces. A peripheral tablet edge delimited between each of the first and second surfaces and the side surface is chamfered to provide a respective inclined peripheral edge face over the entire perimeter of the tablet. This tablet also has at least first generally V-sectioned score defined in the first surface so as to leave two tablet divisions of uniform size on respective sides of the V-sectioned first score. A pair of generally V-sectioned side scores are defined in the side surface of the tablet at respective locations opposite to each other and continued to opposite ends of the V-sectioned first score. The tablet can be divided along the V-sectioned score in the first surface by the application of a minimized finger pressure. The tablet of the invention is particularly suited in a pharmaceutical field. <IMAGE>
Patent DE-69232153-T2 (DE)
Inventor: BHATNAGAR RAJENDRA S
IPC: C12N5/00
Filed: 1992-12-03
Granted: 2002-06-27
Abstract: Compositions of the invention include composites comprising a biomaterial carrying compounds with enhanced cell binding with respect to collagen. These composites are useful for soft and hard tissue repair or reconstruction. Suitable compounds with enhanced cell binding include synthetic peptides that mimic the conformation necessary for recognition and docketing of collagen binding species (such as cell surface receptors for collagen and fibronectin). Hydrogel matrices as the biomaterial promote cell attachment to the matrix and cell migration into the matrix.